AI assistant
CalciMedica, Inc. — Director's Dealing 2025
Jun 26, 2025
34649_dirs_2025-06-26_d4812cd7-b94b-4f98-bdbb-7bf6bdf918da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CalciMedica, Inc. (CALC)
CIK: 0001534133
Period of Report: 2025-06-24
Reporting Person: MIDDLETON FRED A (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-24 | Director Stock Option (Right to Buy) | $1.53 | A | 10000 | Acquired | 2035-04-22 | Common Stock (10000) | Direct |
| 2025-06-24 | Director Stock Option (Right to Buy) | $1.53 | A | 6562 | Acquired | 2035-04-22 | Common Stock (6562) | Direct |
| 2025-06-24 | Director Stock Option (Right to Buy) | $1.53 | A | 19687 | Acquired | 2035-04-22 | Common Stock (19687) | Direct |
| 2025-06-24 | Director Stock Option (Right to Buy) | $1.65 | A | 10000 | Acquired | 2035-06-23 | Common Stock (10000) | Direct |
Footnotes
F1: The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.
F2: 1/12th of the shares subject to the option vest in equal monthly installments over a one year period following March 26, 2025.
F3: Immediately exercisable.
F4: 1/9th of the shares subject to the option vest in equal monthly installments over a one year period following April 1, 2025.
F5: 1/12th of the shares subject to the option vest in equal monthly installments over a one year period following June 24, 2025, provided that the shares will in any case be fully vested on the date of Company's 2026 annual meeting of stockholders.